ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AD02 | B | Tacrolimus monohydrate - 3mg | 7641 | 186523/13 | ADVAGRAF | 3mg | 100 | Capsule, prolonged release | Oral | Abela Frères S.A.L. | Astellas Ireland Co Ltd | Ireland | 68,645,618 L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AD02 | B | Tacrolimus monohydrate - 3mg | 7641/388 | 186523/13 | ADVAGRAF | 3mg | 100 | Capsule, prolonged release | Oral | Abela Frères S.A.L. | Astellas Ireland Co Ltd | Ireland | L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 05/02/20 |